Cocrystal Prediction of Bexarotene by Graph Convolution Network and Bioavailability Improvement
Bexarotene (BEX) was approved by the FDA in 1999 for the treatment of cutaneous T-cell lymphoma (CTCL). The poor aqueous solubility causes the low bioavailability of the drug and thereby limits the clinical application. In this study, we developed a GCN-based deep learning model (CocrystalGCN) for i...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Bog |
Udgivet: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Fag: | |
Online adgang: | Connect to this object online. |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Internet
Connect to this object online.3rd Floor Main Library
Klassifikationsnummer: |
A1234.567 |
---|---|
Kopi 1 | Tilgængelig |